SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending as investors debate the impact of high-profile data center infrastructure contracts and institutional ownership amidst ongoing price volatility and sector-wide sentiment shifts. The community remains deeply divided, with some highlighting the company's long-term potential in the AI-driven energy sector while others express frustration over recent price declines and the lack of immediate upward momentum.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is facing significant volatility as investors digest a wave of 13F regulatory filings from major hedge funds and institutions, while the community remains sharply divided over the company's aggressive debt load versus its massive revenue backlog and AI infrastructure contracts. Traders are actively debating whether recent price swings represent a healthy consolidation for a long-term growth play or a speculative pump-and-dump cycle driven by institutional rotation and high-beta exposure.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending after a sharp sell-off triggered by lower revenue guidance and an upcoming leadership transition, despite reporting strong transaction margins and profitability. Investors are heavily debating whether the dip presents a bargain for long-term growth or if the company's competitive position and reliance on consumer debt are worsening.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is currently under intense pressure following an earnings miss that highlighted declining legacy search revenue and margin compression, leading to significant volatility. While some investors are scaling into the stock as a contrarian play on its deep value relative to its cash reserves and long-term AI potential, others are actively betting against it, citing concerns over the broader weakness in Chinese tech and the lack of clarity on a spin-off for its chip division.

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals is seeing intense investor activity as market participants closely monitor the ongoing Phase 3 LUCIDITY trial of avexitide for post-bariatric hypoglycemia. The community is heavily debating the stock's potential for a significant buyout or parabolic rise, with many traders actively discussing dilution risks and short interest alongside optimism surrounding the company's clinical pipeline.

Fabrinet engages in the provision of optical packaging and electronic manufacturing services to original equipment manufacturers. The firm's engineering services include process design, failure analysis, reliability testing, tooling design, and real-time traceability system. Its manufacturing operations offer sensors, subsystems, customized optics, and optical modules and components. The company was founded by David Thomas Mitchell on August 12, 1999 and is headquartered in George Town, Cayman Islands.

Fabrinet

Fabrinet shares are experiencing significant volatility following a post-earnings sell-off that has sparked intense debate among traders regarding the company's valuation, cash flow metrics, and future growth outlook. While some investors are viewing the price correction as an attractive entry point for a long-term position, others remain skeptical, citing concerns over profit margins, inventory levels, and historical patterns of post-earnings volatility.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is facing intense bearish sentiment and volatility ahead of its upcoming earnings report, with community members actively discussing concerns over debt refinancing, potential accounting irregularities, and federal investigations. Investors remain sharply divided between those calling for a collapse of the stock due to structural risks and those anticipating a potential short squeeze fueled by institutional positioning.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing significant selling pressure as investors weigh the start of a major multi-state legal trial regarding social media's impact on youth alongside broader concerns about elevated AI infrastructure spending. While some community members are treating the decline as a buying opportunity based on historical valuation, others are concerned that ongoing litigation and high capital expenditure could create a prolonged period of volatility.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is trending due to strong commercial performance of CARVYKTI, which recently pushed the company toward its first profitable quarter. Investors are actively discussing the company's robust balance sheet, the potential of its in vivo CAR-T pipeline, and ongoing speculation regarding a possible buyout by major pharmaceutical partners.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trading in a tight range as investors weigh strong contracted data center backlog against broader market volatility and a lack of recent news catalysts. While the community remains divided between those frustrated by the stock's sluggish movement compared to sector peers and long-term bulls accumulating shares on dips, discussion is centered on the potential for institutional accumulation and the anticipation of new lease announcements to break the current technical stalemate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BCRX if the big buyers are in at $9.70 it is a steal for the little guys at $10. They would not get in this stock if they believed it would not go up from here.Look for $12 to start the week off and by Friday the price, if Trump doesn’t do some screwy thing, will be $15 and if the war ends $20 and higher. The only thing holding this down will be bad management and a Trump Garfunkel . Keep the movement going up and by July 4th we will be near $30..I got in on Thursday after doing major research. I do believe we see a lot of offers from big pharma companies but if played right with all the new things in the pipeline it would be crazy to let a company come in at $20 whereas in a month that price will be a joke of a offer and $30,$40 will be the competitive offer.
Look for rumors of a buyout about to happen but like good execs do they negotiate with no news offered until a major deal is signed. I have been with AZpLD since it was at $3 and now into this. I do see me making a million soon

Supporting Ukraine

Justin

ktrader1991

no1patfan

Jake

brent roningen

Mr. Phat

Dennis Alles

Darian DelMastro

HeadHunter

Finger_roll_

gaetano

Joseph Dinchuk

zaltenbairt

$BCRX frustrating to see this nonsense generic bio post. Pumpery waste of scrolling time and clogging up the feed worse than adds. Please report to get these folks banned

StockTwits for iOS

JMStockTwits

Carl Burt

Biocryst Pharmaceuticals Inc.

 if the big buyers are in at $9.70 it is a steal for the little guys at $10. They would not get in this stock if they believed it would not go up from here.Look for $12 to start the week off and by Friday the price, if Trump doesn’t do some screwy thing, will be $15 and if the war ends $20 and higher. The only thing holding this down will be bad management and a Trump Garfunkel . Keep the movement going up and by July 4th we will be near $30..I got in on Thursday after doing major research. I do believe we see a lot of offers from big pharma companies but if played right with all the new things in the pipeline it would be crazy to let a company come in at $20 whereas in a month that price will be a joke of a offer and $30,$40 will be the competitive offer.
Look for rumors of a buyout about to happen but like good execs do they negotiate with no news offered until a major deal is signed. I have been with AZpLD since it was at $3 and now into this. I do see me making a million soon

Tiffany

@tkr they would be rock starts to get $25-30. The realistic range of a buyout that is good for both parties is $20-$35

 they would be rock starts to get $25-30. The realistic range of a buyout that is good for both parties is $20-$35

@tkr BCRX has never followed the macro. You’re new here and need to take a deep breath. If BCRX followed the macro we’d be at 700 dollars a share.

The Options Jedi

 BCRX has never followed the macro. You’re new here and need to take a deep breath. If BCRX followed the macro we’d be at 700 dollars a share.